Argo Graphene Solutions Corp. (CSE:ARGO)

Theseus Pharmaceuticals Balance Sheet

Financials in millions CAD. Fiscal year is December - November.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 31, 2025	Nov 30, 2024	Nov 30, 2023	Nov 30, 2022	Nov 30, 2021	Nov 30, 2020
Cash & Equivalents	0.32	0.09	0.1	0.08	0.33	0.2
Cash & Short-Term Investments	0.32	0.09	0.1	0.08	0.33	0.2
Cash Growth	104.94%	-12.68%	17.67%	-74.23%	64.85%	2188.42%
Other Receivables	0.01	0.01	0.01	0	0.01	0
Receivables	0.01	0.01	0.01	0	0.01	0
Prepaid Expenses	0.09	0.03	0.01	0.01	0	0
Total Current Assets	0.42	0.12	0.11	0.09	0.34	0.2
Property, Plant & Equipment	-	-	0.03	0.09	0.1	0.03
Total Assets	0.42	0.12	0.14	0.18	0.44	0.23
Accounts Payable	0.03	0.02	0	0	0	0
Accrued Expenses	0.03	0.06	0.03	0.03	0.01	0.02
Short-Term Debt	-	-	-	0.03	0.03	-
Current Portion of Leases	-	-	-	0.01	0.01	0.01
Total Current Liabilities	0.06	0.09	0.03	0.07	0.05	0.03
Long-Term Leases	-	-	-	-	0	0.01
Total Liabilities	0.06	0.09	0.03	0.07	0.05	0.04
Common Stock	3.09	2.01	1.24	0.89	0.86	0.28
Additional Paid-In Capital	0.01	0.01	0.01	0.01	0.01	0.01
Retained Earnings	-4.26	-2.2	-1.39	-0.81	-0.53	-0.09
Comprehensive Income & Other	1.53	0.21	0.25	0.02	0.03	-
Shareholders' Equity	0.36	0.04	0.11	0.12	0.38	0.2
Total Liabilities & Equity	0.42	0.12	0.14	0.18	0.44	0.23
Total Debt	-	-	-	0.03	0.04	0.02
Net Cash (Debt)	0.32	0.09	0.1	0.05	0.28	0.18
Net Cash Growth	104.94%	-12.68%	100.44%	-82.68%	56.91%	1999.81%
Net Cash Per Share	0.02	0.01	0.01	0.01	0.04	0.09
Filing Date Shares Outstanding	18.28	18.31	13.04	10.69	9.19	5.04
Total Common Shares Outstanding	18.28	14.93	11.08	9.19	9.1	5.04
Working Capital	0.36	0.04	0.08	0.03	0.29	0.17
Book Value Per Share	0.02	0.00	0.01	0.01	0.04	0.04
Tangible Book Value	0.36	0.04	0.11	0.12	0.38	0.2
Tangible Book Value Per Share	0.02	0.00	0.01	0.01	0.04	0.04
Machinery	-	-	0.04	0.1	0.09	0.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.